Semaglutide biosimilar(Guangzhou Baiyunshan Baidi Biotech)
司美格鲁肽生物类似药（广州白云山拜迪生物医药）
Report date: 2026/02/25 14:21:33
Base Information
Drug NameSemaglutide biosimilar(Guangzhou Baiyunshan Baidi Biotech)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesGuangzhou Baiyunshan Baidi Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuangzhou Baiyunshan Baidi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A